Fulvestrant 70771-1626
Product NDC
70771-1626- Manufacturer
- Zydus Lifesciences Limited
- Dosage Form
- Injection, Solution
- Route
- Intramuscular
- Product Type
- Human Prescription Drug
- Marketing Start
- December 14, 2021
- Listing Expires
- December 31, 2026
- Application
- ANDA215234
Need to source Fulvestrant? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Fulvestrant | 50 mg/mL |
Drug Class
Estrogen Receptor Antagonist [EPC]Estrogen Receptor Antagonist [EPC]Estrogen Receptor Antagonists [MoA]
Packaging Options(1)
2 SYRINGE, GLASS in 1 CARTON (70771-1626-8) / 5 mL in 1 SYRINGE, GLASS (70771-1626-2)